FI4069690T3 - Triatsolisienilääkeyhdiste pc945:n polymorfeja - Google Patents
Triatsolisienilääkeyhdiste pc945:n polymorfeja Download PDFInfo
- Publication number
- FI4069690T3 FI4069690T3 FIEP20824979.7T FI20824979T FI4069690T3 FI 4069690 T3 FI4069690 T3 FI 4069690T3 FI 20824979 T FI20824979 T FI 20824979T FI 4069690 T3 FI4069690 T3 FI 4069690T3
- Authority
- FI
- Finland
- Prior art keywords
- crystalline form
- compound
- pharmaceutical composition
- spp
- composition according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1917867.2A GB201917867D0 (en) | 2019-12-06 | 2019-12-06 | Polymorphs |
| PCT/GB2020/053107 WO2021111142A1 (en) | 2019-12-06 | 2020-12-04 | Polymorphs of triazole antifungal compound pc945 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI4069690T3 true FI4069690T3 (fi) | 2025-01-21 |
Family
ID=69171938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIEP20824979.7T FI4069690T3 (fi) | 2019-12-06 | 2020-12-04 | Triatsolisienilääkeyhdiste pc945:n polymorfeja |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US12491182B2 (enExample) |
| EP (2) | EP4069690B1 (enExample) |
| JP (1) | JP2023505227A (enExample) |
| KR (1) | KR20220110726A (enExample) |
| CN (1) | CN114746415B (enExample) |
| AU (1) | AU2020397613A1 (enExample) |
| BR (1) | BR112022006259A2 (enExample) |
| CA (1) | CA3155829A1 (enExample) |
| CL (1) | CL2022001464A1 (enExample) |
| CO (1) | CO2022007808A2 (enExample) |
| DK (1) | DK4069690T3 (enExample) |
| ES (1) | ES3000984T3 (enExample) |
| FI (1) | FI4069690T3 (enExample) |
| GB (1) | GB201917867D0 (enExample) |
| HR (1) | HRP20250042T1 (enExample) |
| HU (1) | HUE069799T2 (enExample) |
| IL (1) | IL293401A (enExample) |
| LT (1) | LT4069690T (enExample) |
| MX (1) | MX2022006654A (enExample) |
| PL (1) | PL4069690T3 (enExample) |
| PT (1) | PT4069690T (enExample) |
| RS (1) | RS66401B1 (enExample) |
| SA (1) | SA522432879B1 (enExample) |
| SI (1) | SI4069690T1 (enExample) |
| SM (1) | SMT202400514T1 (enExample) |
| WO (1) | WO2021111142A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2963625C (en) | 2014-12-05 | 2023-08-22 | Pulmocide Limited | 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl)piperazin-1-yl)-n-(4-fluorophenyl)benzamide or salts thereof, and use to treat mycoses |
| CN117510488B (zh) * | 2022-07-28 | 2025-12-05 | 博瑞制药(苏州)有限公司 | 一种硫酸艾沙康唑的制备方法 |
| CN117330660A (zh) * | 2023-09-14 | 2024-01-02 | 广州医科大学附属第一医院（广州呼吸中心） | Uplc-ms/ms联用检测艾沙康唑的方法及应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1292472C (en) | 1985-12-03 | 1991-11-26 | Alfonsus Guilielmus Knaeps | Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles |
| WO1989004829A1 (en) | 1987-11-20 | 1989-06-01 | Schering Corporation | Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof |
| US5039676A (en) | 1990-05-11 | 1991-08-13 | Schering Corporation | Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof |
| AU681753B2 (en) | 1993-12-21 | 1997-09-04 | Merck Sharp & Dohme Corp. | Tetrahydrofuran antifungals |
| US5714490A (en) | 1993-12-21 | 1998-02-03 | Schering Corporation | Tetrahydrofuran antifungals |
| US5486625A (en) | 1994-07-08 | 1996-01-23 | Schering Corporation | Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents |
| AU5928096A (en) | 1995-06-02 | 1996-12-18 | Schering Corporation | Tetrahydrofuran antifungals |
| EP0957101A1 (en) | 1998-05-14 | 1999-11-17 | Janssen Pharmaceutica N.V. | Water soluble azoles as broad-spectrum antifungals |
| EP1372394A1 (en) | 2001-04-03 | 2004-01-02 | Schering Corporation | Antifungal composition with enhanced bioavailability |
| EP2141159A1 (en) * | 2008-07-03 | 2010-01-06 | Sandoz AG | A Crystalline form of posaconazole |
| WO2013036866A1 (en) | 2011-09-07 | 2013-03-14 | The Johns Hopkins University | Itraconazole analogs and use thereof |
| CA2963625C (en) * | 2014-12-05 | 2023-08-22 | Pulmocide Limited | 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl)piperazin-1-yl)-n-(4-fluorophenyl)benzamide or salts thereof, and use to treat mycoses |
-
2019
- 2019-12-06 GB GBGB1917867.2A patent/GB201917867D0/en not_active Ceased
-
2020
- 2020-12-04 EP EP20824979.7A patent/EP4069690B1/en active Active
- 2020-12-04 KR KR1020227012753A patent/KR20220110726A/ko active Pending
- 2020-12-04 ES ES20824979T patent/ES3000984T3/es active Active
- 2020-12-04 LT LTEPPCT/GB2020/053107T patent/LT4069690T/lt unknown
- 2020-12-04 CN CN202080082529.6A patent/CN114746415B/zh active Active
- 2020-12-04 PT PT208249797T patent/PT4069690T/pt unknown
- 2020-12-04 JP JP2022533459A patent/JP2023505227A/ja active Pending
- 2020-12-04 HR HRP20250042TT patent/HRP20250042T1/hr unknown
- 2020-12-04 FI FIEP20824979.7T patent/FI4069690T3/fi active
- 2020-12-04 SI SI202030565T patent/SI4069690T1/sl unknown
- 2020-12-04 CA CA3155829A patent/CA3155829A1/en active Pending
- 2020-12-04 EP EP24212504.5A patent/EP4509179A3/en active Pending
- 2020-12-04 RS RS20250045A patent/RS66401B1/sr unknown
- 2020-12-04 MX MX2022006654A patent/MX2022006654A/es unknown
- 2020-12-04 US US17/782,232 patent/US12491182B2/en active Active
- 2020-12-04 BR BR112022006259A patent/BR112022006259A2/pt unknown
- 2020-12-04 AU AU2020397613A patent/AU2020397613A1/en active Pending
- 2020-12-04 WO PCT/GB2020/053107 patent/WO2021111142A1/en not_active Ceased
- 2020-12-04 SM SM20240514T patent/SMT202400514T1/it unknown
- 2020-12-04 DK DK20824979.7T patent/DK4069690T3/da active
- 2020-12-04 PL PL20824979.7T patent/PL4069690T3/pl unknown
- 2020-12-04 HU HUE20824979A patent/HUE069799T2/hu unknown
- 2020-12-04 IL IL293401A patent/IL293401A/en unknown
-
2022
- 2022-06-01 CO CONC2022/0007808A patent/CO2022007808A2/es unknown
- 2022-06-02 CL CL2022001464A patent/CL2022001464A1/es unknown
- 2022-06-05 SA SA522432879A patent/SA522432879B1/ar unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SA522432879B1 (ar) | 2025-01-26 |
| WO2021111142A1 (en) | 2021-06-10 |
| US12491182B2 (en) | 2025-12-09 |
| EP4509179A3 (en) | 2025-02-26 |
| HUE069799T2 (hu) | 2025-04-28 |
| AU2020397613A1 (en) | 2022-06-02 |
| JP2023505227A (ja) | 2023-02-08 |
| CN114746415A (zh) | 2022-07-12 |
| CL2022001464A1 (es) | 2023-03-24 |
| IL293401A (en) | 2022-07-01 |
| LT4069690T (lt) | 2025-01-10 |
| US20230028714A1 (en) | 2023-01-26 |
| BR112022006259A2 (pt) | 2022-06-21 |
| SI4069690T1 (sl) | 2025-03-31 |
| PT4069690T (pt) | 2024-12-13 |
| RS66401B1 (sr) | 2025-02-28 |
| KR20220110726A (ko) | 2022-08-09 |
| GB201917867D0 (en) | 2020-01-22 |
| DK4069690T3 (da) | 2025-01-20 |
| CO2022007808A2 (es) | 2022-06-30 |
| ES3000984T3 (es) | 2025-03-04 |
| MX2022006654A (es) | 2022-09-07 |
| EP4069690B1 (en) | 2024-11-13 |
| SMT202400514T1 (it) | 2025-01-14 |
| HRP20250042T1 (hr) | 2025-03-14 |
| EP4069690A1 (en) | 2022-10-12 |
| PL4069690T3 (pl) | 2025-03-10 |
| CN114746415B (zh) | 2025-04-11 |
| EP4509179A2 (en) | 2025-02-19 |
| CA3155829A1 (en) | 2021-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI4069690T3 (fi) | Triatsolisienilääkeyhdiste pc945:n polymorfeja | |
| JP2011500779A5 (enExample) | ||
| -H. Zhou et al. | Recent researches in triazole compounds as medicinal drugs | |
| RU2189982C2 (ru) | Азольные соединения, способ их получения, противогрибковая фармацевтическая композиция и способ лечения грибковой инфекции | |
| EP1254659B1 (en) | Stable emulsion compositions | |
| CN107001343B (zh) | 抗真菌的化合物 | |
| EP1511490A2 (en) | Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods | |
| EP1143959B1 (en) | Antifungal activity of dicationic molecules | |
| JP2017536371A5 (enExample) | ||
| JP2017519036A5 (enExample) | ||
| US7446107B2 (en) | Crystalline forms of conazoles and methods of making and using the same | |
| NZ613167A (en) | Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds | |
| REZKI et al. | Green ultrasound-assisted three-component click synthesis of novel 1H-1, 2, 3-triazole carrying benzothiazoles and fluorinated-1, 2, 4-triazole conjugates and their antimicrobial evaluation | |
| US4782059A (en) | Method of controlling mycotic infections and compositions therefor | |
| JP2007534764A5 (enExample) | ||
| WO2008019030A2 (en) | Modified azole compounds as antiinfective agents | |
| JPWO2021111142A5 (enExample) | ||
| JPWO2006118329A1 (ja) | 安定な乳化組成物 | |
| Sorbera et al. | Albaconazole | |
| JP2018520104A5 (enExample) | ||
| US20020193384A1 (en) | Use of azoles for the preventing skin cancer | |
| WO2005118577A1 (en) | Novel saperconazole crystalline forms and related processes, pharmaceutical compositions and methods | |
| AU749760B2 (en) | 2,4,4-trisubstituted-1,3-dioxolane antifungals | |
| US6583164B1 (en) | Antimycotic drug composition | |
| WO2019106571A1 (en) | Dosing regimens for the treatment of fungal infections |